Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
January 7, 2014
BRATTLEBORO, Vt.The U.S. Patent and Trademark Office has issued NutraGenesis a patent covering its WellBody 365® nutraceutical ingredient, a combination of beta glucan and ashwagandha. The patent covers the composition that enhances immune activity during chronic stress by increasing cytokines and phagocytosis, NutraGenesis said. The ingredient contains a clinically tested, multi-patented immunomodulating Maitake mushroom extract with the standardized ashwagandha extract Sensoril®.
WellBody 365® represents a departure from traditional immune-modulators that simply address immune support," said company president and managing director Suzanne McNeary. "Patented WellBody 365® is the next-generation immune nutraceutical that provides immune modulation as well as dramatic resistance to stress for broad spectrum, daily support and protection of immune function."
You May Also Like
Patents can offer supplement brands competitive advantageMar 1, 2024
Five tips for creating an irresistible snack bar – articleMar 1, 2024
SupplySide Education Series: Microbiome: Beyond probiotics – webinarMar 21, 2024
A self-regulated supplement industry is the path to responsible innovationFeb 29, 2024